Post-Transplantation Lymphoproliferative Disorder After Kidney Transplantation: Report of a Nationwide French Registry and the Development of a New Prognostic Score

Abstract

This nationwide study highlights the prognostic factors for PTLD and enables the development of a new prognostic score. After validation in an independent cohort, the use of this score should allow treatment strategies to be better tailored to individual patients in the future.

References

Page 1

	Year	Citations
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization Alan S. Go, Glenn M. Chertow, Dongjie Fan, New England Journal of Medicine	2004	11.2K
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma New England Journal of Medicine	1993	4.9K
A predictive model for aggressive non-Hodgkin's lymphoma Margaret A. Shipp, David P. Harrington, J R Anderson, Lymphoid NeoplasiaAggressive Non-hodgkinMedicinePathologyLymphatic Disease	1993	3.5K
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai, Blood	2006	1.5K
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY Thomas E. Starzl, K. A. Porter, Shunzaburo Iwatsuki, The Lancet Lymphoid NeoplasiaSurgical PathologyPathologyLymphatic DiseaseDermatology	1984	1.3K
Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report Gerhard Opelz, Bernd Döhler American Journal of Transplantation Kidney RecipientsSolid Organ TransplantationImmunologyPathologySurgery	2004	1.1K
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Patrick Maisonneuve, Lawrence Y. Agodoa, Ryszard Gellert, The Lancet International Collaborative StudyHemodialysisUrologyRenal DiseaseOncology	1999	873
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Michael A. Nalesnik, Ronald Jaffe, Thomas E. Starzl, PubMed	1988	703
Posttransplant Lymphoproliferative Disorders after Renal Transplantation in the United States in Era of Modern Immunosuppression Sophie Caillard, Vikas R. Dharnidharka, Lawrence Y. Agodoa, Transplantation	2005	401
REDUCTION IN IMMUNOSUPPRESSION AS INITIAL THERAPY FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: ANALYSIS OF PROGNOSTIC VARIABLES AND LONG-TERM FOLLOW-UP OF 42 ADULT PATIENTS1 Donald E. Tsai, Christine Hardy, John E. Tomaszewski, Transplantation	2001	363

Page 1